Fri November 13th, 2020
Sponsor: Rep. David McKinley — R — WV
Creates additional requirements for drug manufacturers and distributors who discover a suspicious order for controlled substances. In addition to reporting the suspicious order to the Drug Enforcement Administration (DEA), a manufacturer or distributor must also exercise due diligence and decline to fill the order. The DEA must issue regulations specifying the indicators that give rise to a suspicious order.
Don't be sad- we've got your back. Just enter your email below and instructions on resetting your password will be sent to you.×